Daily Brief Archive: July 14, 2026 — U.S. & Hong Kong Stock Analysis

Free preview

U.S. Markets

  • SK Hynix cratered 15.4% — its worst day ever — dragging the SOX down; SOXL fell 14% in one session
  • KOSPI plunged 9.95%, tripping its 7th circuit breaker this year; Samsung -10.7%, index now 27% off the June peak
  • US-Iran strikes escalated: Tehran declared Hormuz 'unnavigable'; Brent jumped 5% through $80
  • Energy bucked the tape: XLE +3%, XOP +4.2%; richly valued software dumped — AppLovin's 5-day slide hit -18.6%
  • Oracle fell 6.5% for a ninth straight loss and a fresh 52-week low — no antidote yet for the capex-and-debt narrative
  • Microsoft +1.5% and IBM +0.9%: defensive money hid in big-cap value tech

Hong Kong

  • Hang Seng opened soft this morning; tech lagged — Baidu fell as much as 8% to lead decliners, Zhipu -10%
  • Kunlunxin's IPO 'bundling' clause stirred controversy; the market voted with its feet on Baidu's spin-off premium
  • Oil & petrochemicals outperformed: Sinopec +2.4%; Zijin +3.3% as gold-copper repair continued
  • CXO names hit highs against the tape: Asymchem +4.9% near a record, WuXi Bio printed another swing high
  • GigaDevice V-bounced 9.5% the day after its lock-up expiry; MiniMax caught a 3.3% oversold breather
  • Lithium bounced from oversold: Ganfeng +2.8%, Tianqi +3.3% — the weekly wounds are far from healed

Today's Watchlist

  • Tonight 8:30pm HKT: US June CPI — consensus sees 4.2%→3.9%, core 2.9%; the year's biggest data point
  • All five megabanks report premarket tonight; the SpaceX IPO lifts group IB revenue estimates by 26%
  • New Fed Chair Warsh gives his first Congressional testimony; markets are pricing rising odds of a September hike
  • Hormuz: US floats a maritime blockade plus a 20% transit levy — oil risks a second spike
  • Position tripwires: TSLA $390, NVDA $196, BEAM $30.5, CELH $29.6
  • Ahead: TSLA and IBM report 7/22; SpaceX's first earnings and first lock-up expiry land 8/6

Deep Dives (2 names)

Long
Score7/101-month +38.7%To 52-wk high HK$130 — one step awayRSI(14) 66.8Sector echo WuXi Bio (2269, held) printing highs in tandemBank target avg HK$136.1

Technicals — A fully bullish MA stack (20-day HK$108, 50-day HK$101, 200-day HK$89), with this morning's 4.9% push on 1.24x volume pressing the HK$130 prior high. This isn't a one-day melt-up chase — it's a month of stair-step gains, and RSI at 66.8 is warm, not burnt.

Fundamentals — CXO demand is flowing back — innovative-drug licensing plus a warming peptide/small-molecule order cycle has made interim-season order visibility a safe-harbor theme for HK money. The July 8 H-share incentive grant (at RMB 1.00) locks in the core team.

News — Shares rose 6.7% on July 9 when the incentive grant was disclosed; with WuXi Bio printing highs in tandem, CXO is one of the few long themes on a red tech tape. Two bank buy ratings in 90 days, average target HK$136.1.

Short-term · 1–3 weeks
Long Lean bullish

Breakout channel, sector confirmation (2269 at highs too) and a stair-step monthly climb — triple confirmation. The HK$115 stop allows 1.5 ATRs (HK$8.75); a break means being wrong, and the entire dignity of new-high trading lives in the stop.

Entry Scale in inside HK$122–128; a volume close above HK$130 confirms the breakoutStop HK$115Target HK$145
Long-term · months+
Accumulate

A warming CXO cycle with rising utilization, big order elasticity in peptides (GLP-1 spillover), and the RMB-1 incentive grant aligning management.

  • Geopolitical risk (Biosecure-style bills) resurfacing
  • Order-cycle volatility
  • Adverse A/H premium convergence
Community Voices
  • 雪球 · CXO chatter is heating up — bagholders from the last cycle top are still lecturing new buyers, which is the standard soundtrack of an advance's first halfOriginal ↗
Institutional Views
  • 华尔街共识 · 7 analysts average HK$133 — 4.2% above spot at a 1.07 rating; targets are being chased higher by the price
  • 搜狐财经 · H-share incentive granted; two buy ratings in 90 days with an average target of HK$136.1Source ↗
Long
Score8/101-week +15.2%Cloud growth (preview) ~45%, above expectationsAI products Qwen 4.0 iteration + 3 AI product lines mergedStop HK$105Consensus target HK$185 (+67%)

Technicals — A quiet consolidation after the 15% week: the 7-day RSI at 74.8 is short-term hot but the daily RSI of 56 is healthy. The 20-day sits far below at HK$101.4 with the 50-day at HK$116.8 as the next gate. Flat this morning against a falling tech index — relative strength intact.

Fundamentals — The FY27Q1 preview points to cloud growth accelerating to ~45% (above expectations) with EBITA margin reaching low double digits; Qwen 4.0 plus the QoderWork/Wukong/MuleRun productivity suite gives the 'reprice AI assets' narrative something real to hold.

News — After the two-stage jump (+12% on 7/8, +5% on 7/9), rotation has settled in and the banks' 'time to reprice AI assets' call keeps working; a flat close on a red HS Tech morning says the holder base hasn't loosened.

Short-term · 1–3 weeks
Long Bullish

Low-volume consolidation after a surge is a bullish shape, counter-tape strength is valuable, and the stop already sits above cost — this is the textbook let-it-run setup, not a take-profit one.

Entry Hold; a pullback to HK$105–107 remains the only dignified boarding zone for those who missed itStop HK$105Target HK$130
Long-term · months+
Accumulate

The cloud+AI re-rating is still early with a valuation discount to US peers as the cushion; core-commerce cash flow funds the capex cycle.

  • LLM monetization underdelivering
  • Regulatory whiplash
  • Weak consumption dragging the core
Signal BacktestCumulative +10.77%price itself +17.75%0/1 closed trades wonprofitable since 07-09
  • 07-02LongHK$94.5 → closed HK$94.107-04-0.42%
  • 07-08LongHK$99.6 → open → HK$110.8+11.24%
Community Voices
  • 雪球 · The 'phase two of the AI re-rating' camp battles the 'take the money' camp — the sidelined wait for a dip, and a dip that never comes is the market's cruelest trickOriginal ↗
Institutional Views
  • 华尔街共识 · 34 analysts average HK$185 — 67% above spot; 1.16 rating
  • 新浪财经 · Banks: it's time to reprice AI assetsSource ↗

Rapid Scan (9 names)

TickerCloseChangeScoreDirectionOne-line take
700 logo700HKHK$456.2-0.31%6LongDown 0.3% this morning at HK$456.20, 1.4% above the HK$450 stop — still the same exam question: is the trend alive; above the line, holding
1211 logo1211HKHK$86.15+2.62%7LongUp 2.6% this morning at HK$86.15 — the export story refuels while OEM pricing keeps decoupling from lithium; stop HK$78, holding
1810 logo1810HKHK$26.04+0.77%7LongUp 0.8% this morning at HK$26.04 with momentum intact after an 11.8% week — the lock-up-storm survivor rides on; holding
3690 logo3690HKHK$79.2+1.60%6LongUp 1.6% this morning at HK$79.20, turning higher out of a strong consolidation; holding
1801 logo1801HKHK$90.05+1.07%7LongUp 1.1% this morning at HK$90.05, extending the swing high — the innovative-drug theme is +22.5% on the month; holding
2269 logo2269HKHK$38.2+2.36%7LongUp 2.4% this morning at a fresh high of HK$38.20 — the CXO duo resonates (Asymchem pressing records the same day); stop raised to HK$35, holding
2899 logo2899HKHK$30.5+3.25%7LongUp 3.3% this morning at HK$30.50 — stage three of the gold-copper repair flips the position into the green; holding
2259 logo2259HKHK$103+5.64%6LongUp 5.6% this morning at HK$103.00, hitting escape velocity off the stop line — last week's patience just paid interest; stop stays HK$95
5 logo5HKHK$152.6-0.78%7LongDown 0.8% this morning at HK$152.60, quietly consolidating at the highs — still the least demanding position of the storm week; holding
Stock Brief 2026-07-14: Daily U.S. & HK Market Analysis Archive · Quant Brief